U-0126

N/A

Report date: 2023/12/05 10:55:29

NME

Base Information

Drug NameU-0126

Drug Alias NameU-0126U0126

ClassificationSmall molecules

Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase 1 inhibitorsDual specificity mitogen-activated protein kinase kinase 2 inhibitors

TargetsDual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2

Therapy Area/IndicationsStroke

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC +[2]

Active IndicationsN/A

Inactive IndicationsStroke

Other Information

ATC CodeN/A